Late Stage Capitalism
Physician, Long-Term Stock Investor with 30 Years of Experience
Core Scientific's selloff over doubts about CoreWeave misses that, if CoreWeave cannot meet its obligations, Core Scientific can re-lease that capacity at 40-60% higher rates. Most of its capacity is tied to CoreWeave, which is why the stock is being hit as CoreWeave's viability is questioned. x.com
CoreWeave looks like a poor long because its debt now exceeds its market capitalization. x.com
CoreWeave could face a liquidity squeeze if customer prepayments funded parent needs or unrelated data centers while their own projects still need financing. Most of its >$7B in deferred revenue likely reflects prepayments. If credit tightens significantly, it could fail to complete projects, triggering delays or cancellations, refund demands and a cascading crisis. Signed projects still look economical, but its financing market has deteriorated meaningfully since June. x.com x.com x.com x.com
CoreWeave's $35B in debt against $5B in equity and three customers providing 72% of sales leave it financially vulnerable. Its CDS at 1,047 bps implies a 58% chance of default within five years; Lehman's was about 700 bps the Friday before it filed, though Lehman was seen as much more systemic. Jensen Huang may understand CoreWeave better than anyone, but rescuing it could require buying the remaining 87% of its equity and assuming about $40B in debt. x.com x.com x.com x.com
CoreWeave's falling credit-risk spread and record-volume lower low point to possible capitulation after severe news. Its five-year CDS has fallen nearly 500 basis points from a 1,500-basis-point high; over the past two weeks it faced the worst news short of bankruptcy, including a CDS scare and Elon Musk spreading fear about neoclouds. This could be the bottom if the stock reclaims its July 29 level. x.com
CoreWeave's debt-funded GPUs make financing costs central to its business, while credit markets now price severe distress. Its five-year CDS reached 1,194 basis points on October 15 and remained near 1,145 last week, implying roughly 60% default odds over five years. If yields fall after the FOMC yet shares cannot hold $50, the balance sheet deserves more scrutiny than the macro backdrop. x.com
CoreWeave's record-high credit-default swaps flag risk to the buying case. Liquid Trading says its bonds are distressed and the swaps price in a greater than 50% chance of default within five years. Even so, CoreWeave is a "crazy discount" that needs to recover from recent negative narratives before it takes off. x.com x.com x.com
CoreWeave's debt burden made its IPO dead on arrival, and the burden is even worse now. Debt threatens the equity case. x.com
CoreWeave's debt level puts it at default risk. The market's sudden alarm reflects old balance-sheet news, not a new deterioration. x.com
CoreWeave's stock may already reflect much of its real financing risk amid extreme pessimism. Its unsecured bonds yield distressed rates and CDS spreads have surged, while Q2 net interest expense was $640M and 2026 capex guidance is $35–39B. Q2 revenue was $2.58B with about $104B of backlog, but whether that demand yields shareholder value after financing, depreciation and reinvestment remains uncertain; attractive financing is central to the case. x.com
CoreWeave's $7.5B debt maturity around June 2027 is stressing its credit. Default insurance on its debt costs about 11.2% a year; at a standard 40% recovery rate, that implies roughly 61% risk-neutral five-year default odds, up from about 31% in June. Despite a bond rebound reported by DeItaone, CoreWeave is distressed, not dead. x.com
